Glenmark Life Sciences is setting up an active pharmaceutical ingredients (API) manufacturing unit with a capacity of 999.70 million tpa at Chincholi MIDC, in Solapur district of Maharashtra.

The project will come up over 40 acre of land parcel. The Ministry of Environment, Forest and Climate Change (MoEF&CC) has granted environmental clearance for the project.

Work on the project has commenced.

The project is expected to be completed by July 2025.

here is company details.

 

NOTE :You need to login first to access this feature.